We are live on ! Find out more
GRTS

Gritstone bio, Inc. Common Stock

Delisted

GRTS was delisted on the 21st of October, 2024.

85 hedge funds and large institutions have $120M invested in Gritstone bio, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 28 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital invested

Capital invested by funds: $97.1M → $120M (+$23.3M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less funds holding

Funds holding: 8885 (-3)

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

21% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 28

75% less call options, than puts

Call options by funds: $3.13M | Put options by funds: $12.8M

Holders
85
Holders Change
-3
Holders Change %
-3.41%
% of All Funds
1.22%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
14
Increased
22
Reduced
28
Closed
17
Calls
$3.13M
Puts
$12.8M
Net Calls
-$9.64M
Net Calls Change
-$10.2M
Name Holding Trade Value Shares
Change
Change in
Stake
ASN
101
Advisory Services Network
Georgia
-$1.39K -680 Closed
Zurich Cantonal Bank
102
Zurich Cantonal Bank
Switzerland
-$979 -480 Closed

GRTS Hedge Fund Activity: Q1 2024 in Review

85 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q1 2024, worth a combined $120M — up 24% from $97.1M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of GRTS and 14 opened new positions — a net loss of 3 holders — while 28 trimmed existing stakes and 22 added.

The largest buyer was Deutsche Bank, opening a new position worth an estimated $7.28M. The largest seller was Morgan Stanley, cutting an estimated $10.5M.

  • 85 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q1 2024, down from 88 in Q4 2023.
  • Funds reported $120M of Gritstone bio, Inc. Common Stock stock for Q1 2024, up 24% quarter-over-quarter.
  • 14 funds opened new Gritstone bio, Inc. Common Stock positions in Q1 2024 and 17 closed out, a net change of -3 holders.
  • The largest Gritstone bio, Inc. Common Stock buyer in Q1 2024 was Deutsche Bank, an estimated $7.28M added.
  • The largest Gritstone bio, Inc. Common Stock seller in Q1 2024 was Morgan Stanley, an estimated $10.5M sold.

Based on aggregated 13F filings for Q1 2024.